Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...

After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved. A tough biotech investing environment, aggressive direct-to-consumer drug marketing ...

Drug development is notoriously failure-prone. Only one in every ten drug candidates that enter human trials eventually goes onto the market. Turning a promising molecule into a useful medicine ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Next week, ...

West Pharmaceutical Services plans to move into the former BWI Group building, located at 989 Opportunity Parkway in Greenfield. A worldwide leader in injectable drug administration will be the newest ...

Add Johnson & Johnson to the list of biopharma giants that have struck most-favored-nation (MFN) drug pricing deals with the Trump administration. With the agreement—which frees J&J up from tariffs on ...

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is ...

Jan 8 (Reuters) - Merck (MRK.N), opens new tab is in talks to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab in a $28 billion to $32 billion deal, the Financial Times reported ...

2024 US pharma trade deficit was $115.5B, with largest deficit of $45.5B with Ireland. Trump proposed 100% tariffs on certain pharma imports to encourage US drug manufacturing. US imports most ...